Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122708) titled 'A clinical trial of combined natural compound regimen : assessment of safety, tolerability, and preliminary antitumor efficacy in patients with advanced solid tumor' on April 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Condition:
Solid tumor
Intervention:
Phase Ia: experimental group:BPSC for oral dose escalation
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-04-17
Target Sample Size: Phase Ia: experimental group:12;Phase Ib: experimental group:30;
Cou...